KB801
KB801-01
Phase 2 mab active
Quick answer
KB801 for Neurotrophic Keratitis is a Phase 2 program (mab) at Krystal Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Krystal Biotech
- Indication
- Neurotrophic Keratitis
- Phase
- Phase 2
- Modality
- mab
- Status
- active